Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. (Q39603245)
Jump to navigation
Jump to search
scientific article published on 24 January 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. |
scientific article published on 24 January 2011 |
Statements
Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45 (English)
Hiroyuki Yamamoto
Choon-Taek Lee
Yasuhisa Shinomura
Yoshiaki Arimura
Takao Endo
Hirokazu Ohashi
Yongfen Min
Hua Li
Masanori Ii
David P Carbone
24 January 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference